Meyka AI API is live for developers.Start building.
Advertisement
Agile Therapeutics, Inc.

Agile Therapeutics, Inc. (AGRX) Stock Overview

Explore Agile Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AGRX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.51
$0.05(3.42%)
U.S. Market opens in 48h 56m
Advertisement

Agile Therapeutics, Inc. (AGRX)

Meyka AI Score

Z

Key Financials

Market Cap10.4M
P/E Ratio-0.23
EPS (TTM)$-1.70
ROE1.32%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$268.67

AGRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Agile Therapeutics, Inc. (AGRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $268.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.23 and a market capitalization of 10.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
3.62%
3-Month Change
376.34%
6-Month Change
169.16%
Year-to-Date (YTD) Change
-17.93%
1-Year Change
-12.72%
3-Year Change
-99.93%
5-Year Change
-99.93%
All-Time (Max) Change
-99.99%

Contact Information

https://www.agiletherapeutics.com
609 683 1880
500 College Road East, Princeton, NJ, 08540

Company Facts

190 Employees
IPO DateMay 23, 2014
CountryUS

Frequently Asked Questions